Cargando…
Coadministration of Anti-Viral Monoclonal Antibodies With Routine Pediatric Vaccines and Implications for Nirsevimab Use: A White Paper
Routine childhood vaccinations are key for the protection of children from a variety of serious and potentially fatal diseases. Current pediatric vaccine schedules mainly cover active vaccines. Active vaccination in infants is a highly effective approach against several infectious diseases; however,...
Autores principales: | Esposito, Susanna, Abu-Raya, Bahaa, Bonanni, Paolo, Cahn-Sellem, Fabianne, Flanagan, Katie L., Martinon Torres, Federico, Mejias, Asuncion, Nadel, Simon, Safadi, Marco A. P., Simon, Arne |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8386277/ https://www.ncbi.nlm.nih.gov/pubmed/34456918 http://dx.doi.org/10.3389/fimmu.2021.708939 |
Ejemplares similares
-
Safety of routine childhood vaccine coadministration versus separate vaccination
por: Bauwens, Jorgen, et al.
Publicado: (2022) -
RSV Prevention in All Infants: Which Is the Most Preferable Strategy?
por: Esposito, Susanna, et al.
Publicado: (2022) -
Inequalities in Health Impact of Alternative Reimbursement Pathways for Nirsevimab in the United States
por: Gomez, Gabriela B, et al.
Publicado: (2022) -
Nirsevimab brings breakthrough in the prevention of respiratory syncytial virus infection in infants – Importance of design
por: Zhaori, Getu
Publicado: (2023) -
89. The Impact of Nirsevimab on an RSV Season in All Infants: Data From The HARMONIE Study
por: Faust, Saul N, et al.
Publicado: (2023)